p38 MAP kinase activity modulates αβ T cell development

Thomas Mulroy, Jyoti Sen

Research output: Contribution to journalArticle

Abstract

Reciprocal interactions between bone marrow derived precursor cells and the thymic environment lead to the generation of the complete repertoire of diverse and functional T cells. We have previously shown that p38 MAP kinase is activated in response to intrathymic signals in thymocytes. In this report we provide evidence that p38 MAP kinase activity is essential for pre-TCR-mediated transition of thymocytes from the CD4- CD8- to the CD4+ CD8+ stage of development. In the absence of p38 MAP kinase activity differentiation of αβ T cells, but not γδ T cells, was blocked.

Original languageEnglish (US)
Pages (from-to)3056-3063
Number of pages8
JournalEuropean Journal of Immunology
Volume31
Issue number10
DOIs
StatePublished - 2001
Externally publishedYes

Fingerprint

p38 Mitogen-Activated Protein Kinases
Thymocytes
T-Lymphocytes
Bone Marrow

Keywords

  • p38 MAP kinase
  • Pre-T cell receptor
  • Signal transduction
  • Thymus

ASJC Scopus subject areas

  • Immunology

Cite this

p38 MAP kinase activity modulates αβ T cell development. / Mulroy, Thomas; Sen, Jyoti.

In: European Journal of Immunology, Vol. 31, No. 10, 2001, p. 3056-3063.

Research output: Contribution to journalArticle

Mulroy, Thomas ; Sen, Jyoti. / p38 MAP kinase activity modulates αβ T cell development. In: European Journal of Immunology. 2001 ; Vol. 31, No. 10. pp. 3056-3063.
@article{81b9cd92ec424778ac3ecfbb0fec35a3,
title = "p38 MAP kinase activity modulates αβ T cell development",
abstract = "Reciprocal interactions between bone marrow derived precursor cells and the thymic environment lead to the generation of the complete repertoire of diverse and functional T cells. We have previously shown that p38 MAP kinase is activated in response to intrathymic signals in thymocytes. In this report we provide evidence that p38 MAP kinase activity is essential for pre-TCR-mediated transition of thymocytes from the CD4- CD8- to the CD4+ CD8+ stage of development. In the absence of p38 MAP kinase activity differentiation of αβ T cells, but not γδ T cells, was blocked.",
keywords = "p38 MAP kinase, Pre-T cell receptor, Signal transduction, Thymus",
author = "Thomas Mulroy and Jyoti Sen",
year = "2001",
doi = "10.1002/1521-4141(2001010)31:10<3056::AID-IMMU3056>3.0.CO;2-B",
language = "English (US)",
volume = "31",
pages = "3056--3063",
journal = "European Journal of Immunology",
issn = "0014-2980",
publisher = "Wiley-VCH Verlag",
number = "10",

}

TY - JOUR

T1 - p38 MAP kinase activity modulates αβ T cell development

AU - Mulroy, Thomas

AU - Sen, Jyoti

PY - 2001

Y1 - 2001

N2 - Reciprocal interactions between bone marrow derived precursor cells and the thymic environment lead to the generation of the complete repertoire of diverse and functional T cells. We have previously shown that p38 MAP kinase is activated in response to intrathymic signals in thymocytes. In this report we provide evidence that p38 MAP kinase activity is essential for pre-TCR-mediated transition of thymocytes from the CD4- CD8- to the CD4+ CD8+ stage of development. In the absence of p38 MAP kinase activity differentiation of αβ T cells, but not γδ T cells, was blocked.

AB - Reciprocal interactions between bone marrow derived precursor cells and the thymic environment lead to the generation of the complete repertoire of diverse and functional T cells. We have previously shown that p38 MAP kinase is activated in response to intrathymic signals in thymocytes. In this report we provide evidence that p38 MAP kinase activity is essential for pre-TCR-mediated transition of thymocytes from the CD4- CD8- to the CD4+ CD8+ stage of development. In the absence of p38 MAP kinase activity differentiation of αβ T cells, but not γδ T cells, was blocked.

KW - p38 MAP kinase

KW - Pre-T cell receptor

KW - Signal transduction

KW - Thymus

UR - http://www.scopus.com/inward/record.url?scp=0034781509&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034781509&partnerID=8YFLogxK

U2 - 10.1002/1521-4141(2001010)31:10<3056::AID-IMMU3056>3.0.CO;2-B

DO - 10.1002/1521-4141(2001010)31:10<3056::AID-IMMU3056>3.0.CO;2-B

M3 - Article

C2 - 11592082

AN - SCOPUS:0034781509

VL - 31

SP - 3056

EP - 3063

JO - European Journal of Immunology

JF - European Journal of Immunology

SN - 0014-2980

IS - 10

ER -